is sport betting profitable

is sport betting profitable Pathstone Holdings LLC lessened its stake in ResMed Inc. ( NYSE:RMD – Free Report ) by 2.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 16,473 shares of the medical equipment provider’s stock after selling 468 shares during the period. Pathstone Holdings LLC’s holdings in ResMed were worth $4,021,000 at the end of the most recent reporting period. Several other hedge funds have also made changes to their positions in the stock. UMB Bank n.a. lifted its stake in shares of ResMed by 1.9% in the third quarter. UMB Bank n.a. now owns 2,465 shares of the medical equipment provider’s stock valued at $602,000 after buying an additional 47 shares during the period. QRG Capital Management Inc. lifted its stake in shares of ResMed by 4.5% in the second quarter. QRG Capital Management Inc. now owns 1,291 shares of the medical equipment provider’s stock valued at $247,000 after buying an additional 56 shares during the period. Inspire Advisors LLC lifted its stake in shares of ResMed by 1.9% in the second quarter. Inspire Advisors LLC now owns 3,060 shares of the medical equipment provider’s stock valued at $586,000 after buying an additional 56 shares during the period. Concurrent Investment Advisors LLC lifted its stake in ResMed by 3.1% during the third quarter. Concurrent Investment Advisors LLC now owns 1,919 shares of the medical equipment provider’s stock worth $469,000 after purchasing an additional 57 shares during the period. Finally, Moss Adams Wealth Advisors LLC lifted its stake in ResMed by 2.0% during the third quarter. Moss Adams Wealth Advisors LLC now owns 3,043 shares of the medical equipment provider’s stock worth $743,000 after purchasing an additional 60 shares during the period. Institutional investors own 54.98% of the company’s stock. Analyst Upgrades and Downgrades RMD has been the subject of a number of analyst reports. Baird R W upgraded shares of ResMed to a “strong-buy” rating in a research note on Tuesday, September 24th. Royal Bank of Canada raised their price target on shares of ResMed from $224.00 to $232.00 and gave the stock a “sector perform” rating in a research note on Friday, October 25th. Needham & Company LLC restated a “hold” rating on shares of ResMed in a research note on Friday, October 25th. StockNews.com upgraded shares of ResMed from a “hold” rating to a “buy” rating in a research note on Tuesday, October 15th. Finally, KeyCorp raised their price target on shares of ResMed from $251.00 to $266.00 and gave the stock an “overweight” rating in a research note on Friday, October 25th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $225.70. Insiders Place Their Bets In other news, insider Kaushik Ghoshal sold 5,000 shares of ResMed stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $252.56, for a total transaction of $1,262,800.00. Following the transaction, the insider now directly owns 21,788 shares of the company’s stock, valued at $5,502,777.28. This trade represents a 18.67 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink . Also, Director Witte Jan De sold 796 shares of ResMed stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $248.81, for a total transaction of $198,052.76. Following the transaction, the director now directly owns 6,723 shares in the company, valued at approximately $1,672,749.63. This represents a 10.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here . In the last 90 days, insiders sold 62,174 shares of company stock valued at $14,882,278. Company insiders own 0.71% of the company’s stock. ResMed Stock Performance Shares of ResMed stock opened at $243.78 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.92 and a quick ratio of 1.91. The firm has a market cap of $35.79 billion, a P/E ratio of 32.29, a P/E/G ratio of 1.77 and a beta of 0.69. The firm has a 50 day simple moving average of $241.86 and a 200 day simple moving average of $224.47. ResMed Inc. has a fifty-two week low of $151.95 and a fifty-two week high of $260.49. ResMed ( NYSE:RMD – Get Free Report ) last released its earnings results on Thursday, October 24th. The medical equipment provider reported $2.20 EPS for the quarter, topping analysts’ consensus estimates of $2.03 by $0.17. ResMed had a net margin of 23.15% and a return on equity of 25.53%. The firm had revenue of $1.22 billion during the quarter, compared to analyst estimates of $1.19 billion. During the same quarter in the previous year, the business earned $1.64 EPS. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. Sell-side analysts predict that ResMed Inc. will post 9.28 earnings per share for the current fiscal year. ResMed Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Thursday, November 7th will be issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 0.87%. The ex-dividend date of this dividend is Thursday, November 7th. ResMed’s dividend payout ratio is presently 28.08%. ResMed Company Profile ( Free Report ) ResMed Inc develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. Featured Stories Receive News & Ratings for ResMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ResMed and related companies with MarketBeat.com's FREE daily email newsletter .

The International Institute for Sustainable Development (IISD) has recommended that India prioritise local production of key battery components, including synthetic anodes, electrolytes and cell casings and pouches. The institute suggested implementing supportive regulations and trade and industrial policies to help India maximise its comparative advantages in the electric vehicle (EV) battery supply chain. India has the opportunity to scale up its battery production, thanks to the presence of domestic suppliers, strong cost competitiveness and low reliance on intellectual property and foreign technology, IISD indicated in a report. It pointed out that the Indian government should incentivise the development of domestic cathodes, the highest-value components in a battery cell. While India’s technology-agnostic approach could support the development of various battery types, IISD suggested prioritising lithium ferro phosphate (LFP) cathodes due to their lower cost and suitability for India’s climatic conditions. Adopting LFP batteries could also help reduce reliance on critical mineral imports like cobalt and nickel. To seize future opportunities in the battery industry, IISD suggested that the Indian government support research and development (R&D) and incentivise the commercialisation of next-generation technologies like sodium-ion and solid-state batteries. The institute further urged India to adopt clearer environmental, social, and governance (ESG) guidelines and robust reporting frameworks to boost the global competitiveness of domestic battery companies. It also highlighted the importance of increased public investment in establishing cell fabrication and testing centres with trained workers to ensure the quality of raw materials, components, and equipment. In addition, the government should create incentives for a circular economy by promoting the recycling of end-of-life batteries and improving the efficiency of used battery collection. IISD noted that China is currently grappling with significant overcapacity across the battery supply chain, which makes it more challenging for Indian companies to compete in a saturated market. Despite this, India can potentially add significant value to the global battery supply chain. Localisation of critical equipment used in cell manufacturing should be prioritised through technology partnerships and trade agreements with key allies. The country’s chemical sector expertise, technological capabilities, favourable trade and geopolitical relations with countries like South Korea, Japan, the United States, and the European Union, and its growing network of free trade agreements with mineral-rich nations provide India with several opportunities. There is room for India to diversify away from China for some equipment through collaboration with free trade agreement partners, but it will need to consider the cost implications on downstream battery companies, it said. Acknowledging the role of India’s Production Linked Incentive (PLI) scheme for Advanced Chemistry Cells (ACC) in kick-starting the growth of the EV battery ecosystem, IISD stated that accelerated investments and regulatory support will be crucial for India to become a competitive player in the rapidly evolving automotive supply chain and EV battery technology landscape. Comments

Hearts 1-4 Celtic: No slip-ups this time as Rodgers' ruthless side stretch lead over faltering rivals By STEPHEN MCGOWAN Published: 17:30 EST, 24 November 2024 | Updated: 17:30 EST, 24 November 2024 e-mail View comments With the help of their new data analysis partners at Jamestown Analytics, Hearts are planning for the January transfer window. They have a goalscoring striker in mind and the work to make it happen has already begun. This time last season, Lawrence Shankland had 12 goals to his name en route to the best season of his life. Like Samson shorn of his golden locks, the Scotland striker’s powers have waned. A free agent at the end of the season, it’s difficult for him to keep his focus on the opposition goal if he has one eye on the exit. There should be no criticism of Shankland’s general link-up play. The cushioned header which presented Blair Spittal with a glorious chance after two minutes carried on his intelligent work in the recent defeat to Rangers at Ibrox. The problems lie in front of goal, where the predatory finisher of old has lost his touch and confidence. Pressing to distraction, Neil Critchley’s side threatened to take advantage of Celtic ’s familiar lethargy after an international break. Right-back Alistair Johnston had only returned back from North America last Friday morning and, as Hearts’ best player James Penrice rampaged down the left flank — throwing in cross after cross — the home team crafted the best chances of the first half. Kyogo Furuhashi celebrates scoring the opening goal in Celtic's 4-1 victory against Hearts Substitute Adam Idah rounds off the scoring with a penalty at Tynecastle on Saturday night Rodgers shakes hands with Hearts' Lawrence Shankland, who has lost his touch in front of goal Penrice made it to the byeline after 18 minutes and cut the ball back for a mouth-watering opportunity. Shankland scuffed it wide with his left foot. Three minutes later, former Livingston full-back Penrice galloped into space once again and hung up a perfect cross for the captain at the back post. Kasper Schmeichel gathered the ball easily. Celtic were spooked and uncomfortable. Cammy Devlin harangued and harried Callum McGregor into an unusual number of possession turnovers. Towards the end of the first period, Celtic’s captain took the ball in front of his back four and motioned for movement in front of him. There was no response. Hearts had to score in those opening 45 minutes when they had the champions on the ropes. Failure to take three excellent chances cost them. Surprised by the Hearts press, Brendan Rodgers made adaptations at half-time and, inevitably, the energy and the running of their opponents waned. Goals change games and, when Celtic scored two in five minutes early in the second half, they never looked back. Money in the bank reflects the quality a team can afford in front of goal — and the Parkhead side have more cash and more quality than everyone else. Unbeaten in their last 27 domestic games, the last team to actually defeat them was Hearts. That contentious loss in Edinburgh in March came on another weekend when Rangers dropped points at home. On a day when the Ibrox side drew against Dundee United and Aberdeen lost to St Mirren, Celtic refused to entertain any Tynecastle slip-ups this time. In the second half, they were clinical. The obligatory Kyogo Furuhashi goal against the Gorgie side finally came in the 55th minute. There was misfortune for the home side when Daniel Oyegoke’s clearance ricocheted off McGregor and fell into the path of the most lethal finisher on the pitch. Denied by Craig Gordon with his first attempt, the Japanese international claimed his seventh goal of the season with his second, with only his tenth touch of the ball. The debt of gratitude Celtic owe to Nicolas Kuhn’s dentist can’t be overstated. When the German arrived in January, his dental problems contributed to a difficult settling-in period. On current form, he’s the early frontrunner for player of the season. Five minutes after the opener, a devastating Celtic breakaway saw Kuhn burst over the halfway line and play a neat one-two with Daizen Maeda. The German’s explosive left-foot strike fizzed past Gordon into the roof of the net for a superb second goal. In an unusual spectacle, Alan Forrest trotted off for Hearts as his older brother James trotted on for Celtic after 67 minutes. Both Forrest and fellow substitute Adam Idah were to have an impact. Hearts had a huge opportunity to make a game of things when slackness in the Celtic defence presented Shankland with another opportunity. For reasons best known to himself, the striker rolled the ball to Devlin and, while the midfielder got his shot away, Schmeichel saved. ‘I’ve spoken to Shanks about it,’ revealed Devlin afterwards. ‘He thought he was offside, and then I thought he was going to shoot so I wasn’t expecting the set-up. ‘We’ve watched it back there, he was onside, but it’s one of those ones in the heat of the moment. I’ve got my shot off and he (Schmeichel) has made a really good block, to be fair. Maybe I should do better.’ The Australia international was the last Hearts player who should have been beating himself up. A combative, willing runner, he had spent the days leading up to the game acting as a counsellor for team-mate Kenneth Vargas after the Costa Rican gave a foolish interview in his homeland expressing the desire to leave in January to play against ‘better-level players’. Given a cool reception by home fans, Vargas took to the pitch shortly before Idah prodded the ball past Gordon for 3-0 and game over. Urging supporters to show the attacker a little festive spirit and forgiveness, Devlin revealed: ‘I was in Scotland and Kenny texted me saying, “can you please help me, I’ve been misinterpreted”. ‘Kenny’s a young kid and maybe whatever he said he shouldn’t have said. But he’s a lovely guy and I can say hand on my heart that he absolutely loves being here. He loves coming out and we’ve got a really good rapport with him. ‘I don’t think he would have signed his five-year deal if he didn’t love being here, so I know he loves being here. ‘Maybe he said a few things that, you know, were a bit naive and he probably regrets saying. But he’s just a kid and I know he’ll keep working hard.’ Another Hearts substitute, Musa Drammeh, showed Vargas the road to redemption when he thumped a superb strike past Schmeichel to make it 3-1. The consolation was brief when Forrest was fouled by Jorge Grant in the area and Idah claimed his seventh Celtic goal of the season with an emphatic finish from the penalty spot. Share or comment on this article: Hearts 1-4 Celtic: No slip-ups this time as Rodgers' ruthless side stretch lead over faltering rivals e-mail Add commentRichmond Reckless Driver Faces 30-Day Vehicle Impoundment and State Referee Inspection After Performing Donuts